Literature DB >> 22872454

Breast cancer surveillance in patients treated by radiotherapy for Hodgkin's lymphoma.

G Mariscotti1, M Durando, G Ghione, A Luparia, E Regini, C Alfieri, P P Campanino, P Gavarotti, E Brignardello, G Gandini.   

Abstract

PURPOSE: The authors evaluated the relative risk of developing radiation-induced breast cancer (BC) in women treated with radiotherapy for Hodgkin's disease (HD) and analysed the imaging features of these breast neoplasms.
MATERIALS AND METHODS: We retrospectively studied 54 women who had all undergone radiotherapy between 1980 and 2010 (median age, 36.6 years). Women aged ≤30 years were screened with clinical breast examination, ultrasound (US) and, if necessary, mammography; women >30 years had clinical breast examination, US and mammography. Three women underwent magnetic resonance (MR) imaging as well.
RESULTS: Mammography detected seven invasive breast cancers in 6/54 women (11.1%). Median age at diagnosis was 26.1 years for HD and 42.4 for breast cancer. Breast cancer was diagnosed following a median latent period from radiotherapy of 15.1 years. Mean radiation dose was 37.6 Gy in women who developed breast cancer and 31.3 Gy in the other women.
CONCLUSIONS: In our study, women who were exposed to radiation for HD had a 6.2-fold higher risk of developing breast cancer than the general population. In consideration of the young age and high breast density, women aged ≤30 years should be monitored by US and MR imaging; women aged >30 years should be monitored by US, mammography and, when necessary, MR imaging.

Entities:  

Mesh:

Year:  2012        PMID: 22872454     DOI: 10.1007/s11547-012-0862-2

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  49 in total

1.  Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Authors:  Lois B Travis; Deirdre Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Eero Pukkala; Charles F Lynch; David Pee; Susan A Smith; Mars B Van't Veer; Timo Joensuu; Hans Storm; Marilyn Stovall; John D Boice; Ethel Gilbert; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2005-10-05       Impact factor: 13.506

2.  Late effects of treatment for childhood Hodgkin's disease.

Authors:  L B Travis; R E Curtis; J D Boice
Journal:  N Engl J Med       Date:  1996-08-01       Impact factor: 91.245

3.  Second cancers following pediatric Hodgkin's disease.

Authors:  S L Wolden; K R Lamborn; S F Cleary; D J Tate; S S Donaldson
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

4.  Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors.

Authors:  Deirdre A Hill; Ethel Gilbert; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Tom Wiklund; Charles F Lynch; Mars Van't Veer; Hans Storm; Eero Pukkala; Marilyn Stovall; Rochelle E Curtis; James M Allan; John D Boice; Lois B Travis
Journal:  Blood       Date:  2005-07-28       Impact factor: 22.113

5.  Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial.

Authors:  Massimo Bazzocchi; Chiara Zuiani; Pietro Panizza; Chiara Del Frate; Franca Soldano; Miriam Isola; Francesco Sardanelli; Gian Marco Giuseppetti; Giovanni Simonetti; Vincenzo Lattanzio; Alessandro Del Maschio
Journal:  AJR Am J Roentgenol       Date:  2006-06       Impact factor: 3.959

6.  Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of Pediatric Hematology and Oncology.

Authors:  R Sankila; S Garwicz; J H Olsen; H Döllner; H Hertz; A Kreuger; F Langmark; M Lanning; T Möller; H Tulinius
Journal:  J Clin Oncol       Date:  1996-05       Impact factor: 44.544

Review 7.  Breast cancer in women following mantle irradiation for Hodgkin's disease.

Authors:  M H Peters; I M Sonpal; M K Batra
Journal:  Am Surg       Date:  1995-09       Impact factor: 0.688

8.  Increased mortality after successful treatment for Hodgkin's disease.

Authors:  M M Hudson; C A Poquette; J Lee; C A Greenwald; A Shah; X Luo; E I Thompson; J A Wilimas; L E Kun; W M Crist
Journal:  J Clin Oncol       Date:  1998-11       Impact factor: 44.544

Review 9.  Second primary breast cancer after Hodgkin's disease.

Authors:  A Horwich; A J Swerdlow
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

10.  The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage.

Authors:  S J Howell; C Searle; V Goode; T Gardener; K Linton; R A Cowan; M A Harris; P Hopwood; R Swindell; A Norman; J Kennedy; A Howell; A M Wardley; J A Radford
Journal:  Br J Cancer       Date:  2009-08-18       Impact factor: 7.640

View more
  2 in total

1.  Mammography and MRI for screening women who underwent chest radiation therapy (lymphoma survivors): recommendations for surveillance from the Italian College of Breast Radiologists by SIRM.

Authors:  Giovanna Mariscotti; Paolo Belli; Daniela Bernardi; Beniamino Brancato; Massimo Calabrese; Luca A Carbonaro; Beatrice Cavallo-Marincola; Francesca Caumo; Paola Clauser; Laura Martinchich; Stefania Montemezzi; Pietro Panizza; Federica Pediconi; Alberto Tagliafico; Rubina M Trimboli; Chiara Zuiani; Francesco Sardanelli
Journal:  Radiol Med       Date:  2016-07-12       Impact factor: 3.469

Review 2.  Second Cancers in Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma: A Systematic Review by the Fondazione Italiana Linfomi.

Authors:  Luca Nassi; Vitaliana De Sanctis; Giacomo Loseto; Chiara Gerardi; Eleonora Allocati; Sabino Ciavarella; Carla Minoia; Attilio Guarini; Alessia Bari
Journal:  Cancers (Basel)       Date:  2022-01-20       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.